{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T16:15:25Z","timestamp":1700410525392},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1007\/bf03165412","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T06:40:52Z","timestamp":1254292852000},"page":"21-27","source":"Crossref","is-referenced-by-count":4,"title":["Acetazolamide induced myocardial ischemia in patients with severe coronary artery disease"],"prefix":"10.1007","volume":"12","author":[{"given":"Yoriko","family":"Shimotsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Fukuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunehiko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03165412_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1748-1716.1983.tb07202.x","volume":"117","author":"A Hauge","year":"1983","unstructured":"Hauge A, Nicolaysen G, Thoresen M. Acute effects of acetazolamide on cerebral blood flow in man.Acta Physiol Scand 117: 233\u2013239, 1983.","journal-title":"Acta Physiol Scand"},{"key":"BF03165412_CR2","first-page":"41","volume":"35","author":"J Machac","year":"1994","unstructured":"Machac J. Cerebral versus myocardial stress perfusion imaging: role of pharmacological intervention in the diagnostic assessment of flow reserve.J Nucl Med 35: 41\u201343, 1994.","journal-title":"J Nucl Med"},{"key":"BF03165412_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0001-2998(05)80052-2","volume":"21","author":"AP Yudd","year":"1991","unstructured":"Yudd AP, Heertum RLV, Masdeu JC. Interventions and functional brain imaging.Semin Nucl Med 21: 153\u2013158, 1991.","journal-title":"Semin Nucl Med"},{"key":"BF03165412_CR4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00004424-198808000-00003","volume":"23","author":"FJ Bonte","year":"1988","unstructured":"Bonte FJ, Devous MD, Reisch JS. The effect of acetazolamide on regional cerebral blood flow in normal human subjects as measured by single-photon emission computed tomography.Invest Radiol 23: 564\u2013568, 1988.","journal-title":"Invest Radiol"},{"key":"BF03165412_CR5","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1001\/jama.1983.03340210040022","volume":"250","author":"WB Kannel","year":"1983","unstructured":"Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke\u2014the Framingham study.JAMA 250: 2942\u20132946, 1983.","journal-title":"JAMA"},{"key":"BF03165412_CR6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/archsurg.1977.01370110137016","volume":"112","author":"JT Mehigan","year":"1977","unstructured":"Mehigan JT, Buch WS, Pipkin RD, Fogarty TJ. A planned approach to coexistent cerebrovascular disease in coronary artery bypass candidates.Arch Surg 112: 1403\u20131409, 1977.","journal-title":"Arch Surg"},{"key":"BF03165412_CR7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/00000658-198206000-00006","volume":"195","author":"JM Craver","year":"1982","unstructured":"Craver JM, Murphy DA, Jones EL, Curling PE, Bone DK, Smith RB, et al. Concomitant carotid and coronary reconstruction.Ann Surg 195: 712\u2013719, 1982.","journal-title":"Ann Surg"},{"key":"BF03165412_CR8","first-page":"223","volume":"33","author":"K Matsumura","year":"1996","unstructured":"Matsumura K, Nakashima H, Tanaka K, Kitano T, Murashima S, Takeda K, et al. Presurgical evaluation of cerebral perfusion reserve in patients for cardiovascular surgery using Tc-99m ECD SPECT with Diamox enhancement.KAKU IGAKU (Jpn J Nucl Med) 33: 223\u2013231, 1996.","journal-title":"KAKU IGAKU (Jpn J Nucl Med)"},{"key":"BF03165412_CR9","doi-asserted-by":"crossref","unstructured":"Shimotsu Y, Hayashida K, Hirose Y, Kume N, Nishimura T. Combined Tl-201 myocardial with Tc-99m HMPAO brain SPECT: myocardial ischemia induced by acetazolamide in severe coronary artery disease.J Nucl Med (in print) 1998.","DOI":"10.1007\/BF03165412"},{"key":"BF03165412_CR10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0741-5214(87)90312-0","volume":"6","author":"JJ Ricotta","year":"1987","unstructured":"Ricotta JJ, Bryan FA, Bond MG, Kurtz A, O\u2019Leary DH, Raines JK, et al. Multicenter validation study of realtime (B-mode) ultrasound, arteriography, and pathologic examination.J Vasc Surg 6: 512\u2013520, 1987.","journal-title":"J Vasc Surg"},{"key":"BF03165412_CR11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00006231-199612000-00008","volume":"17","author":"K Hayashida","year":"1996","unstructured":"Hayashida K, Hirose Y, Tanaka Y, Iwama T, Miyake Y, Ishida Y, et al. Vasoreactive effect of acetazolamide as a function of time with sequential PET O-15 water measurement.Nucl Med Commun 17: 1047\u20131051, 1996.","journal-title":"Nucl Med Commun"},{"key":"BF03165412_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archinte.1955.00250070040004","volume":"95","author":"A Rusxin","year":"1955","unstructured":"Rusxin A. Acetazolamide (Diamox) diuresis.Arch Int Med 95: 24\u201332, 1955.","journal-title":"Arch Int Med"},{"key":"BF03165412_CR13","first-page":"464","volume":"28","author":"K Shima","year":"1988","unstructured":"Shima K, Hibi N, Tashiro K. Carbonic anhydrase III (CA-III).Shinkeinaika 28: 464\u2013473, 1988.","journal-title":"Shinkeinaika"},{"key":"BF03165412_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00006231-199604000-00160","volume":"17","author":"E Vanninen","year":"1996","unstructured":"Vanninen E, Kuikka JT, Tenhunen-Eskelinen M, Vanninen R, Mussalo H. Haemodynamic effects of acetazolamide in patients with cardiovascular disorders: correlation with calculated cerebral perfusion reserve.Nucl Med Commun 17: 325\u2013330, 1996.","journal-title":"Nucl Med Commun"},{"key":"BF03165412_CR15","first-page":"281","volume":"30","author":"JA Leppo","year":"1989","unstructured":"Leppo JA. Dipyridamole-thallium imaging: the lazy man\u2019s stress test.J Nucl Med 30: 281\u2013287, 1989.","journal-title":"J Nucl Med"},{"key":"BF03165412_CR16","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0002-8703(89)90417-1","volume":"117","author":"HG Stratmann","year":"1989","unstructured":"Stratmann HG, Kennedy HL. Evaluation of coronary artery disease in the patient unable to exercise: alternatives to exercise stress testing.Am Heart J 117: 1344\u20131365, 1989.","journal-title":"Am Heart J"},{"key":"BF03165412_CR17","first-page":"219","volume-title":"Pharmacologic stress testing and other alternative techniques in the diagnosis of coronary artery disease","author":"AS Iskandrian","year":"1996","unstructured":"Iskandrian AS. Pharmacologic stress testing and other alternative techniques in the diagnosis of coronary artery disease.In: Iskandrian AS, Verani MS, eds.2nd ed.. Philadelphia: F.A. Davis Company, pp. 219\u2013241, 1996.","edition":"2nd ed."},{"key":"BF03165412_CR18","first-page":"1595","volume":"37","author":"TL Hwang","year":"1996","unstructured":"Hwang TL, Saenz A, Farrell JJ, Brannon WL. Brain SPECT with dipyridamole stress to evaluate cerebral blood flow reserve in carotid artery disease.J Nucl Med 37: 1595\u20131599, 1996.","journal-title":"J Nucl Med"},{"key":"BF03165412_CR19","first-page":"488","volume":"25","author":"M Hara","year":"1988","unstructured":"Hara M, Hirota Y, Takagi Y, Shimomura O, Takahashi M, Tomiguti S. Evaluation of the distribution of Tc-99m HMPAO in the myocardium (abstract).Jpn J Nucl Med 25: 488, 1988.","journal-title":"Jpn J Nucl Med"},{"key":"BF03165412_CR20","first-page":"12","volume-title":"Brain Blood Flow in Neurology and Psychiatry","author":"DC Costa","year":"1991","unstructured":"Costa DC, Ell PJ. The evolution of rCBF SPET studies.In: Costa DC, Ell PJ (ed.),Brain Blood Flow in Neurology and Psychiatry, 1st. ed., Edinburgh: Churchill Livingstone, pp. 12\u201317, 1991.","edition":"1st. ed."},{"key":"BF03165412_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF00263256","volume":"9","author":"WA Volkert","year":"1984","unstructured":"Volkert WA, Hoffman TJ, Seger RM, Troutner DE, Holmes RA. Tc-99m-propylene amine oxime (Tc-99m-PnPAO); a potential brain radiopharmaceutical.Eur J Nucl Med 9: 511\u2013516, 1984.","journal-title":"Eur J Nucl Med"},{"key":"BF03165412_CR22","first-page":"156","volume":"16","author":"PR Bradley-Moore","year":"1974","unstructured":"Bradley-Moore PR, Lebowitz E, Greene MW, Atkins HL, Ansari AN. Thallium-201 for medical use. II: biologic behavior.J Nucl Med 16: 156\u2013160, 1974.","journal-title":"J Nucl Med"},{"key":"BF03165412_CR23","first-page":"42","volume-title":"Saishin Syuyou-Kakuigaku","author":"N Tonami","year":"1993","unstructured":"Tonami N. Normal distribution of thallium-201.In Hisada K (ed.),Saishin Syuyou-Kakuigaku, 1st ed., Takyo: Kanehara & Co. Ltd, pp. 42\u201343, 1993.","edition":"1st ed."},{"key":"BF03165412_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0038-1629709","volume":"33","author":"L P\u00e1vics","year":"1994","unstructured":"P\u00e1vics L, Gr\u00fcnwald F, Barz\u00f3 P, Ambrus E, Menzel C, Schomburg A, et al. Evaluation of cerebral vasoreactivity by SPECT and transcranial Doppler sonography using the acetazolamide test.Nuklearmedizin 33: 239\u2013243, 1994.","journal-title":"Nuklearmedizin"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03165412\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:54:19Z","timestamp":1558565659000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03165412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["BF03165412"],"URL":"https:\/\/doi.org\/10.1007\/bf03165412","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}